HRT FINANCIAL LP

Position in VIR — Vir Biotechnology, Inc.

CIK 1475597 NEW YORK, NY

Position in VIR

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$3,139,579

-$428,058 QoQ

Shares Held

308,104

-47.9% QoQ

Ownership

0.182%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#58

of 237 holders

Holding Since

Mar 2021

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

HRT FINANCIAL LP holds $857,639,414 across 185 Biotechnology names. VIR ranks #46 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BBIO	BridgeBio Pharma, Inc.	1,089,376	$81,136,724
2	INSM	INSMED Inc	689,981	$73,565,774
3	EXEL	Exelixis, Inc.	929,242	$50,560,057
4	MDGL	Madrigal Pharmaceuticals, Inc.	84,634	$45,444,226
5	AXSM	Axsome Therapeutics, Inc.	178,491	$43,689,242
6	ARWR	Arrowhead Pharmaceuticals, Inc.	498,655	$40,645,369
7	ABVX	Abivax S.A.	270,612	$36,061,755
8	TGTX	Tg Therapeutics, Inc.	622,603	$34,205,808

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,139,579	308,104	-47.9%	Shares	Defined	2026-08-14
2025-12-31	$3,567,637	591,648	+234.7%	Shares	Defined	2026-02-12
2025-09-30	$1,009,436	176,784	-3.1%	Shares	Defined	2025-11-14
2025-06-30	$919,946	182,529	+1071.3%	Shares	Defined	2025-08-14
2025-03-31	$100,977	15,583	-81.5%	Shares	Defined	2025-05-15
2024-12-31	$616,919	84,049	+71.5%	Shares	Defined	2025-02-14
2024-09-30	$367,174	49,022	+38.8%	Shares	Defined	2024-11-12
2024-06-30	$314,223	35,306	-42.2%	Shares	Defined	2024-08-12
2023-12-31	$614,615	61,095	-48.2%	Shares	Defined	2024-02-09
2023-03-31	$2,746,115	118,011	+367.3%	Shares	Defined	2023-05-12
2022-03-31	$649,532	25,254	+22.8%	Shares	Defined	2022-05-16
2021-06-30	$971,982	20,558	-61.7%	Shares	Defined	2021-08-16
2021-03-31	$2,750,020	53,638	—	Shares	Defined	2021-05-17
No filing history on record for this holder in this stock.